Medpace Investors, LLC - Dec 30, 2021 Form 4 Insider Report for Medpace Holdings, Inc. (MEDP)

Role
10%+ Owner
Signature
/s/ Stephen P. Ewald, Authorized Signatory for Medpace Investors, LLC
Stock symbol
MEDP
Transactions as of
Dec 30, 2021
Transactions value $
-$10,892,117
Form type
4
Date filed
1/4/2022, 03:16 PM
Previous filing
Dec 30, 2021
Next filing
Jan 6, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MEDP Common Stock Sale -$3.83M -17.4K -0.31% $220.34 5.52M Dec 30, 2021 Direct F1, F2
transaction MEDP Common Stock Sale -$2.86M -13.1K -0.24% $219.14 5.51M Dec 31, 2021 Direct F1, F3
transaction MEDP Common Stock Sale -$4.2M -19.7K -0.36% $212.70 5.49M Jan 3, 2022 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 1, 2021.
F2 The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $218.835 to $222.14. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.
F3 The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $217.48 to $220.44. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.
F4 The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $210.00 to $217.36. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.